Study of Adefovir Dipivoxil for Korean Patients With Chronic Hepatitis B(CHB) Who Have Completed ADF 103814

Mise à jour : Il y a 4 ans
Référence : NCT00403585

Femme et Homme

Extrait

This is an open label, single-arm, multi-centre extension study for Korean patients with chronic hepatitis B and compensated liver disease who have completed one-year adefovir dipivoxil treatment in ADF103814. The objective is to assess clinical efficacy and safety of long term (up to 3 years) adefovir dipivoxil 10mg therapy.


Critère d'inclusion

  • Hepatitis B, Chronic ,Chronic hepatitis B

Liens